# Pediatrix Medical Group, Inc.: overview

MD · NYSE · CIK 893949 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/md.md) · [Financials](/companies/md/financials.md) · [Filings](/companies/md/filings.md) · [Insiders](/companies/md/insiders.md)

Latest reported revenue: [$501.4m](/filings/0001193125-26-436952.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 29, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001193125-26-436952).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [502 d](/filings/0001193125-26-058074.md) | [458](/filings/0001193125-26-204993.md) | [469](/filings/0001193125-26-331513.md) | [493](/filings/0001193125-26-436952.md) | [494 d](/filings/0001193125-26-058074.md) | [476](/filings/0001193125-26-204993.md) | [488](/filings/0001193125-26-331513.md) | [501](/filings/0001193125-26-436952.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [7.8% d](/filings/0001193125-26-058074.md) | [7.0%](/filings/0001193125-26-204993.md) | [12.8%](/filings/0001193125-26-331513.md) | [13.8%](/filings/0001193125-26-436952.md) | [9.9% d](/filings/0001193125-26-058074.md) | [8.7%](/filings/0001193125-26-204993.md) | [11.7%](/filings/0001193125-26-331513.md) | [13.0%](/filings/0001193125-26-436952.md) |
| Net margin | % | [6.1% d](/filings/0001193125-26-058074.md) | [4.5%](/filings/0001193125-26-436952.md) | [8.4%](/filings/0001193125-26-436952.md) | [14.5%](/filings/0001193125-26-436952.md) | [6.8% d](/filings/0001193125-26-058074.md) | [6.2%](/filings/0001193125-26-436952.md) | [8.2%](/filings/0001193125-26-436952.md) | [9.4%](/filings/0001193125-26-436952.md) |
| Diluted EPS | $ per share | not reported | [0.24](/filings/0001193125-26-204993.md) | [0.46](/filings/0001193125-26-331513.md) | [0.84](/filings/0001193125-26-436952.md) | not reported | [0.36](/filings/0001193125-26-204993.md) | [0.49](/filings/0001193125-26-331513.md) | [0.59](/filings/0001193125-26-436952.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,911](/filings/0000950170-24-016794.md) | [1,972](/filings/0000950170-25-023730.md) | [1,995](/filings/0001193125-26-058074.md) | [2,013](/filings/0001193125-26-058074.md) | [1,914](/filings/0001193125-26-058074.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [10.6%](/filings/0000950170-24-016794.md) | [8.8%](/filings/0000950170-25-023730.md) | [0.4%](/filings/0001193125-26-058074.md) | [(3.4%)](/filings/0001193125-26-058074.md) | [10.9%](/filings/0001193125-26-058074.md) |
| Net margin | % | [6.9%](/filings/0000950170-24-016794.md) | [3.4%](/filings/0000950170-25-023730.md) | [(3.0%)](/filings/0001193125-26-058074.md) | [(4.9%)](/filings/0001193125-26-058074.md) | [8.6%](/filings/0001193125-26-058074.md) |
| Diluted EPS | $ per share | [1.53](/filings/0000950170-24-016794.md) | [0.79](/filings/0000950170-25-023730.md) | [(0.73)](/filings/0001193125-26-058074.md) | [(1.19)](/filings/0001193125-26-058074.md) | [1.94](/filings/0001193125-26-058074.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/md/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $347.4m | 13,714,275 |  | Added +139,902 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $151.6m | 5,985,147 |  | Reduced −168,979 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $106.9m | 4,220,311 |  | Added +363,396 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $91.7m | 3,620,040 |  | Reduced −36,281 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $89.5m | 3,533,248 |  | Added +154,748 |
| [VICTORY CAPITAL MANAGEMENT INC](/funds/1040188.md) | 2026-06-30 | $86.6m | 3,416,913 |  | Reduced −425,020 |
| [WASATCH ADVISORS LP](/funds/814133.md) | 2026-06-30 | $63.3m | 2,498,884 |  | Added +448,360 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $56.4m | 2,226,028 |  | Added +38,061 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $55.5m | 2,192,017 |  | Reduced −1,733,349 |
| [FULLER & THALER ASSET MANAGEMENT, INC.](/funds/1082327.md) | 2026-06-30 | $43.6m | 1,721,451 |  | Added +492,020 |

## Recent filings

[All 1,033 filings](/companies/md/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 07:00 ET | [10-Q](/filings/0001193125-26-436952.md) | Quarterly report, period 2026-09-30 | 0001193125-26-436952 |
| 2026-10-29 | 06:50 ET | [8-K](/filings/0001193125-26-436932.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-436932 |
| 2026-08-04 | 07:00 ET | [10-Q](/filings/0001193125-26-331513.md) | Quarterly report, period 2026-06-30 | 0001193125-26-331513 |
| 2026-08-04 | 06:50 ET | [8-K](/filings/0001193125-26-331488.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-331488 |
| 2026-07-24 | 17:00 ET | [8-K](/filings/0001193125-26-316225.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001193125-26-316225 |
| 2026-07-15 | 07:00 ET | [8-K](/filings/0001193125-26-304033.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-304033 |
| 2026-05-07 | 16:30 ET | [8-K](/filings/0001193125-26-212117.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-212117 |
| 2026-05-05 | 07:00 ET | [10-Q](/filings/0001193125-26-204993.md) | Quarterly report, period 2026-03-31 | 0001193125-26-204993 |
| 2026-05-05 | 06:50 ET | [8-K](/filings/0001193125-26-204982.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-204982 |
| 2026-03-27 | 06:50 ET | [DEF 14A](/filings/0001193125-26-127299.md) | Proxy statement, period 2026-03-25 | 0001193125-26-127299 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-058074.md), filed Feb 19, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/745301ea-2d95-4702-8589-90a8d88a5f75)

## About the filer

- CIK: 893949
- Tickers: MD
- Exchange: NYSE
- SIC code: 8060 Services-Hospitals
- State of incorporation: FL
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 07:14 ET. No prices; not investment advice.